Zavorotny named several CGM device manufacturers as suppliers rather than direct competitors: Abbott, Dexcom, Medtronic, and Eversense. He also referenced Apple as a potential future entrant into the glucose monitoring space, noting that Apple has discussed releasing sensors that measure glucose through light spectrum rather than skin penetration, which would differ from the current CGM technology Nutrisense uses. Zavorotny did not provide revenue or customer figures for any of these companies, and none of the figures he cited about them should be taken as those companies' confirmed data. No direct software or consumer health competitors were named in the interview.